Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.2883
+0.1173 (68.60%)
At close: Jan 30, 2026
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $1.33 million as of January 30, 2026. Its market cap has decreased by -65.24% in one year.
Market Cap
1.33M
Enterprise Value
-259.50K
Revenue
389.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.29
Market Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 1.33M, a decrease of -95.08%. That is a compound annual growth rate of -61.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.33M | 60.17% |
| Dec 31, 2025 | 831.75K | -77.44% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agentix | 1.80M |
| Carisma Therapeutics | 1.74M |
| Galera Therapeutics | 1.60M |
| inTerra Resources | 1.49M |
| Sorrento Therapeutics | 1.36M |
| ZyVersa Therapeutics | 1.30M |
| Halberd | 1.20M |
| CERo Therapeutics Holdings | 1.19M |